Flecainide acetate is a potent class IC anti-arrhythmic drug with a major sodium channel blocking effect. Flecainide toxicity can cause myocardial impairment and precipitate circulatory collapse. It may also result in life-threatening arrhythmia, although cases of flecainide-induced torsades de pointes are rare. Furthermore, the electrical and hemodynamic deteriorations observed during flecainide toxicity may not respond to conventional treatments. In the present study, we report the case of a 20-year-old Korean man with flecainide poisoning, who presented with hypotension. The patient was successfully treated with sodium bicarbonate, amiodarone, MgSO4, and lidocaine, with no recourse to extracorporeal therapy. Although there is no standard therapy for flecainide toxicity, this report demonstrates that intensive pharmacological treatment is beneficial in cases of flecainide overdose.
Flecainide-Induced Torsade de Pointes Successfully Treated with Intensive Pharmacological Therapy

Introduction
Flecainide is a class IC anti-arrhythmic drug that acts by blocking the fast inward sodium channels during phase 0 of action potential. It is used to treat both supraventricular and ventricular arrhythmias. However, flecainide is also a pro-arrhythmic agent, and overdose may cause nausea, vomiting, hypotension, 2 In particular, the rate-dependent conduction slowing associated with the flecainide has been implicated as a potential mechanism for drug proarrhythmia.
The risk of pro-arrhythmia was reported in patients with myocardial infarction, who were taking flecainide. Although flecainide suppresses conductivity, it may perpetuate reentry in patients with structural heart disease. Flecainide-induced proarrhythmia has rarely been reported in patients with no structural heart disease. Instead, it is most often found in patients taking other anti-arrhythmic drugs, having electrolyte disorders, or an atrial flutter with a 1:1 ventricular conduction. 3 Since we did not analyze flecainide blood levels, we could not confirm if this was a case of flecainide toxicity. However, since toxicity is suggested when there is a 50% increase in the duration of QRS or 30% increase in the prolongation of the PR interval, it is likely. . Timeline representation of events. After the administration of sodium bicarbonate, amiodarone, magnesium sulfate, and lidocaine, the wide and irregular heart rhythm was restored to a sinus rhythm. CPR. cardiopulmonary resuscitation, DC. direct current; ER, emergency room; G/W, general ward; ICU, intensive care unit; PEA, pulseless electrical activity; ROSC, return of spontaneous circulation; SBP, systolic blood pressure; VF, ventricular fibrillation; VT, ventricular tachycardia.
Absorption from the gastrointestinal tract is reasonably rapid, with maximum concentration occurring after 3-4 hours post drug ingestion. 4 Flecainide is eliminated, largely unchanged, by the kidney, and is metabolized to some degree by the hepatic cytochrome P450 2D6. It also has a long elimination half-life (7 to 24 hours), which makes the treatment of a severe overdose more difficult. 6 The primary treatment of an acute flecainide overdose should Administration of a hypertonic sodium bicarbonate solution appears to improve the hemodynamic instability resulting from flecainide toxicity. As illustrated in this case, the benefits can be dramatic and occur within minutes, despite the fact that the mechanism of action is complex and involves the combination of an increase of intracellular sodium and pH, resulting in the displacement of flecainide from the sodium channels. 8 However,
there is no recommended dose of sodium bicarbonate. One common practice is to use a bolus of 50 to 100 mEq of hypertonic sodium bicarbonate solution, targeting a pH value of 7.5 to 7.55.
There are several case reports demonstrating that intensive sodium bicarbonate therapy improves survival without resorting to ECMO. 9 In the case reported herein, the total dose of bicarbonate used was above 500 mEq.
There are case reports showing that anti-arrhythmic agents have been used to terminate flecainide-induced arrhythmias; moreover, in several case reports, sinus rhythm was restored soon after the administration of lidocaine. Although lidocaine is also a sodium channel blocker, it is postulated that its fast-on/fast-off kinetics allow it to compete for the sodium channel, hence reversing the toxicity of other more potent sodium channel blockers (such as the class IC agents). 10 Other case reports have identified IV amiodarone or MgSO4 as the principle agent responsible for terminating flecainide-induced ventricular arrhythmias.
11,12
Because hypotension can develop rapidly after a flecainide overdose, hepatic and renal blood flow is reduced. Measures to maintain vital organ perfusion will enhance flecainide clearance and its redistribution to other body tissues. One method to provide the hemodynamic support necessary to allow flecainide clearance and redistribution is ECMO. Yasui, et al. 13 showed that this technique allowed flecainide clearance and redistribution to continue in one patient with flecainide overdose, reducing the half-life of the drug to six hours. Since the use of ECMO is accompanied by complications including coagulopathies (requiring blood product support), hemorrhage at the cannulation point, and femoral nerve palsy, it should be used cautiously.
Although there is no standard treatment for flecainide overdose, the case reported here demonstrates that an intensive pharmacological therapy, including the administration of sodium bicarbonate, amiodarone, MgSO 4, and lidocaine, can rescue patients from flecainide toxicity with no recourse to extracorporeal therapy.
